Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Mahler SV et al. |
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. |
2007 |
Neuropsychopharmacology |
pmid:17406653
|
Kopczyńska B |
The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats. |
2007 |
Life Sci. |
pmid:17379256
|
Ferrer B et al. |
Regulation of brain anandamide by acute administration of ethanol. |
2007 |
Biochem. J. |
pmid:17302558
|
Naidu PS et al. |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. |
2007 |
Psychopharmacology (Berl.) |
pmid:17279376
|
Sun Y et al. |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. |
2007 |
Br. J. Pharmacol. |
pmid:17906680
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Ryberg E et al. |
The orphan receptor GPR55 is a novel cannabinoid receptor. |
2007 |
Br. J. Pharmacol. |
pmid:17876302
|
Mulè F et al. |
Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. |
2007 |
Pharmacol. Res. |
pmid:17574859
|
Karsak M et al. |
Attenuation of allergic contact dermatitis through the endocannabinoid system. |
2007 |
Science |
pmid:17556587
|
Bátkai S et al. |
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17557913
|
Williams J et al. |
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. |
2007 |
Anal. Chem. |
pmid:17600384
|
Esposito G et al. |
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17545311
|
Karanian DA et al. |
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17545313
|
Velenovská M and Fisar Z |
Effect of cannabinoids on platelet serotonin uptake. |
2007 |
Addict Biol |
pmid:17508987
|
Sit SY et al. |
Novel inhibitors of fatty acid amide hydrolase. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17459705
|
Lory P and Chemin J |
Towards the discovery of novel T-type calcium channel blockers. |
2007 |
Expert Opin. Ther. Targets |
pmid:17465728
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Raduner S et al. |
Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. |
2007 |
J. Nat. Prod. |
pmid:17497806
|
Wang Y and Wang DH |
Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. |
2007 |
Cardiovasc Hematol Disord Drug Targets |
pmid:17346127
|
Basavarajappa BS |
Critical enzymes involved in endocannabinoid metabolism. |
2007 |
Protein Pept. Lett. |
pmid:17346227
|
Jia Y and Lee LY |
Role of TRPV receptors in respiratory diseases. |
2007 |
Biochim. Biophys. Acta |
pmid:17346945
|
Solinas M et al. |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17351107
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Spivak CE et al. |
The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. |
2007 |
Mol. Pharmacol. |
pmid:17628012
|
Thors L et al. |
Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. |
2007 |
Br. J. Pharmacol. |
pmid:17676056
|
Rettori V et al. |
Endocannabinoids in TNF-alpha and ethanol actions. |
2007 |
Neuroimmunomodulation |
pmid:18073513
|
Akerman S et al. |
Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17018694
|
Shimozawa N et al. |
Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats. |
2007 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:17023553
|
Yang YY et al. |
Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis. |
2007 |
Liver Int. |
pmid:17845532
|
Ghasemi M et al. |
Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors. |
2007 |
BJU Int. |
pmid:17850365
|
Cross-Mellor SK et al. |
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. |
2007 |
Psychopharmacology (Berl.) |
pmid:17111174
|
Ronco AM et al. |
Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. |
2007 |
Pharmacology |
pmid:17114903
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Wheal AJ et al. |
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. |
2007 |
Br. J. Pharmacol. |
pmid:17245361
|
Romero FA et al. |
Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. |
2007 |
J. Med. Chem. |
pmid:17279740
|
Snider NT et al. |
Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17272674
|
Matta JA et al. |
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. |
2007 |
J. Physiol. (Lond.) |
pmid:17038422
|
Solinas M et al. |
The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17210800
|
Pisanti S et al. |
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. |
2007 |
J. Cell. Physiol. |
pmid:17192847
|
Ekins S et al. |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. |
2007 |
Drug Metab. Dispos. |
pmid:17194716
|
Schreiber D et al. |
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. |
2007 |
Anal. Biochem. |
pmid:17196922
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Ortar G et al. |
New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. |
2007 |
J. Med. Chem. |
pmid:18027904
|
Degenhardt BF et al. |
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. |
2007 |
J Am Osteopath Assoc |
pmid:17908831
|
Xu H et al. |
Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. |
2007 |
Am. J. Physiol. Renal Physiol. |
pmid:17913835
|
Athanasiou A et al. |
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17931597
|
Morgese MG et al. |
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. |
2007 |
Exp. Neurol. |
pmid:17900568
|
Hillard CJ et al. |
Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. |
2007 |
J. Mol. Neurosci. |
pmid:17901541
|